The tech giant’s plan to develop the massive data center in Franklin Township was bolstered by a city commission’s vote Wednesday to grant preliminary approval to the company’s request to rezone nearly 470 acres for the project.
The Metropolitan Development Commission also will consider granting a tax break for the first building planned for the complex, which has an estimated cost of $314 million.
Documents dated Aug. 6 also include multiple renderings of the campus, which would include 12 data center buildings, three ancillary buildings and more than 400 parking spots.
City leaders are looking for a new development partner to help with the proposed $15 million overhaul of the historic Indianapolis Catacombs next to the closed City Market. The companies previously involved in the project are navigating challenges involving the nearby Gold Building and the rest of the downtown block’s redevelopment.
With more than $9.5 billion in downtown development reshaping our skyline, the need for consistent, responsive street-level services has never been greater.
Municipal government leaders across Indiana are going pale in the face while they review budget forecasts for the next few years as a sweeping property tax relief law takes effect.
Four data center proposals in the Indianapolis area are facing a dynamic that’s emerging here and elsewhere: The operators working to build data centers here vs. the neighbors trying to stop them.
Indianapolis-based ALK Development LLC plans to spend $10 million to restore the 3060 N. Meridian St. building, currently owned by the city, to a 27-unit housing facility focused on seniors.
1Elevan Biopharmaceuticals plans to relocate to a vacant industrial building near Interstate 69 and East 121st Street, where it expects to build a workforce of at least 120 employees over the next decade.
The redevelopment of the art deco-style building would convert floors four through 14 into hotel rooms, with the first three floors remaining retail and office space.
The Swiss pharmaceutical and diagnostics giant said the move will establish the Indianapolis-based Roche Diagnostics site as a hub for manufacturing of its continuous glucose monitoring system.
